GB0717442D0 - Compositions and uses thereof - Google Patents

Compositions and uses thereof

Info

Publication number
GB0717442D0
GB0717442D0 GBGB0717442.8A GB0717442A GB0717442D0 GB 0717442 D0 GB0717442 D0 GB 0717442D0 GB 0717442 A GB0717442 A GB 0717442A GB 0717442 D0 GB0717442 D0 GB 0717442D0
Authority
GB
United Kingdom
Prior art keywords
relates
present
lipoteichoic acid
pneumothorax
pleural effusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0717442.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB0717442.8A priority Critical patent/GB0717442D0/en
Publication of GB0717442D0 publication Critical patent/GB0717442D0/en
Priority to US12/676,742 priority patent/US8536139B2/en
Priority to ES08788551T priority patent/ES2382501T3/es
Priority to CN2008801059024A priority patent/CN101801392B/zh
Priority to JP2010523589A priority patent/JP5623906B2/ja
Priority to EP08788551A priority patent/EP2194991B1/en
Priority to AT08788551T priority patent/ATE545424T1/de
Priority to PCT/GB2008/003019 priority patent/WO2009030929A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0717442.8A 2007-09-07 2007-09-07 Compositions and uses thereof Ceased GB0717442D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB0717442.8A GB0717442D0 (en) 2007-09-07 2007-09-07 Compositions and uses thereof
US12/676,742 US8536139B2 (en) 2007-09-07 2008-09-08 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax
ES08788551T ES2382501T3 (es) 2007-09-07 2008-09-08 Composiciones que comprende ácido lipoteicoico para uso en el tratamiento de la efusión pleural o neumotorax
CN2008801059024A CN101801392B (zh) 2007-09-07 2008-09-08 含有脂膜酸的用于治疗胸腔积液或气胸的组合物
JP2010523589A JP5623906B2 (ja) 2007-09-07 2008-09-08 胸水貯留または気胸の処置において使用するためのリポテイコ酸を含む組成物
EP08788551A EP2194991B1 (en) 2007-09-07 2008-09-08 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax
AT08788551T ATE545424T1 (de) 2007-09-07 2008-09-08 Zusammensetzungen mit lipoteichonsäure zur verwendung bei der behandlung von pleuraerguss oder pneumothorax
PCT/GB2008/003019 WO2009030929A1 (en) 2007-09-07 2008-09-08 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0717442.8A GB0717442D0 (en) 2007-09-07 2007-09-07 Compositions and uses thereof

Publications (1)

Publication Number Publication Date
GB0717442D0 true GB0717442D0 (en) 2007-10-17

Family

ID=38640413

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0717442.8A Ceased GB0717442D0 (en) 2007-09-07 2007-09-07 Compositions and uses thereof

Country Status (8)

Country Link
US (1) US8536139B2 (cg-RX-API-DMAC7.html)
EP (1) EP2194991B1 (cg-RX-API-DMAC7.html)
JP (1) JP5623906B2 (cg-RX-API-DMAC7.html)
CN (1) CN101801392B (cg-RX-API-DMAC7.html)
AT (1) ATE545424T1 (cg-RX-API-DMAC7.html)
ES (1) ES2382501T3 (cg-RX-API-DMAC7.html)
GB (1) GB0717442D0 (cg-RX-API-DMAC7.html)
WO (1) WO2009030929A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8611854U1 (de) 1986-04-30 1986-06-19 Stahl Gmbh & Co Maschinenfabrik, 7140 Ludwigsburg Kombinierte Vierbruchfalzmaschine
EP2545909A1 (en) * 2011-07-12 2013-01-16 Lunamed AG Combination of D-Amino Acids and Lipoteichoic Acid
EP2589387A1 (en) 2011-11-04 2013-05-08 Lunamed AG Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain
EP2589388A1 (en) 2011-11-04 2013-05-08 Lunamed AG Use of a Teichoic acid for the treatment of malignant ascites
CN103961512A (zh) * 2014-06-02 2014-08-06 王志红 一种用于创伤性气胸护理的中药制剂及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0807185B9 (en) * 1995-01-30 2002-12-11 Lunamed AG Antitumor preparations containing a lipoteichoic acid from steptococcus
WO2005030133A2 (en) 2003-09-22 2005-04-07 Yale University Treatment with agonists of toll-like receptors
WO2008048560A2 (en) 2006-10-16 2008-04-24 Yale University Toll-like receptor agonist regulation of vegf-induced tissue responses

Also Published As

Publication number Publication date
EP2194991A1 (en) 2010-06-16
WO2009030929A1 (en) 2009-03-12
JP5623906B2 (ja) 2014-11-12
JP2010538054A (ja) 2010-12-09
EP2194991B1 (en) 2012-02-15
ATE545424T1 (de) 2012-03-15
ES2382501T3 (es) 2012-06-08
US8536139B2 (en) 2013-09-17
US20110059908A1 (en) 2011-03-10
CN101801392B (zh) 2012-09-05
CN101801392A (zh) 2010-08-11

Similar Documents

Publication Publication Date Title
CY1119140T1 (el) Συνθεσεις αντικωδικευσης και μεθοδοι κατασκευης και χρησης τους
BR112015022197A8 (pt) uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia
MX2010014041A (es) Una forma cristalina de posaconazol.
EA018193B3 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
BR112012010706A2 (pt) composto, composição farmacêutica, combinação do produto farmacêutico, uso de um composto, e, métodos para o tratamento de uma doença ou condição, e para inibir um bromodomínio
GEP201706780B (en) Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
MX337437B (es) Composiciones topicas para conservador o restaurar la integridad de la mucosa.
MX2013003635A (es) Compuestos de n-heteroarilo.
BR112012009214A2 (pt) compostos
MY168413A (en) Amino-substituted imidazopyridazines
PH12013500454A1 (en) Substituted imidazopyridazines
WO2007143607A3 (en) Method of treating atrophic vaginitis
BR112015014458A2 (pt) derivados de manose para o tratamento de infecções bacterianas
WO2011141685A3 (fr) Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants
MX348823B (es) Formulaciones estables de linaclotida.
PE20150199A1 (es) Composiciones farmaceuticas y tratamiento de mastitis
PH12013500784A1 (en) Pharmaceutical compositions comprising nano size droplets of skin whitening agents
MX2010001116A (es) Derivados novedosos de benzamidina, proceso para la preparacion de estos y composicion farmaceutica para la prevencion o el tratamiento de osteoporosis que comprende a los mismos.
ATE545424T1 (de) Zusammensetzungen mit lipoteichonsäure zur verwendung bei der behandlung von pleuraerguss oder pneumothorax
BR112014031306A2 (pt) composição farmacêutica e respectivos usos
MX2009003336A (es) Agentes policiclicos para el tratamiento de infecciones de virus sincitiales respiratorias.
MX2015009348A (es) Composiciones hemostaticas.
EP4335460A3 (en) Compositions and methods for treating granulomatosis with polyangiitis
JP2010538054A5 (cg-RX-API-DMAC7.html)
BR112015023368A2 (pt) método de tratamento de deficiência de vitamina b12

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)